Brian Dowd is a director of investments on the bioscience team at Connecticut Innovations. He previously worked at Pfizer and at Biohaven Pharmaceuticals and Kleo Pharmaceuticals, and earned his Ph.D. from Yale.








At firms with a similar stage, sector and check size.





One email when Brian's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckBrian Dowd is a director of investments on the bioscience team at Connecticut Innovations. He previously worked at Pfizer and at Biohaven Pharmaceuticals and Kleo Pharmaceuticals, and earned his Ph.D. from Yale.
Brian Dowd invests through Connecticut Innovations (CT Innovations), which writes checks of $250K to $1M at pre-seed, seed, series a.
Email [email protected], the firm's inbox for founders, and name Brian in the subject. A warm intro from a founder Connecticut Innovations (CT Innovations) backed works better.
bench scientist at California-based company; business development and portfolio strategy at several pharmaceutical companies in Utah; Biohaven Pharmaceuticals; Kleo Pharmaceuticals; business development support for the Nurtec franchise at Pfizer.
Last updated 2026-10-15. Is this you? Ask for a correction.